Maze Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q1 2024 to Q2 2025

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Maze Therapeutics, Inc. quarterly Operating Income (Loss) history and growth rate from Q1 2024 to Q2 2025.
Maze Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2025 was -$36.5M, a 126% decline year-over-year.

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2025		-$36.5M	-$176M	-126%	Apr 1, 2025	Jun 30, 2025	10-Q	2025-08-12
Q1 2025		-$35.4M	-$7.39M	-26.4%	Jan 1, 2025	Mar 31, 2025	10-Q	2025-05-14
Q2 2024		$140M			Apr 1, 2024	Jun 30, 2024	10-Q	2025-08-12
Q1 2024		-$28M			Jan 1, 2024	Mar 31, 2024	10-Q	2025-05-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.